Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca, Tesaro and Clovis need to slash the cost of PARP meds, watchdog says
AstraZeneca, Tesaro and Clovis need to slash the cost of PARP meds, watchdog says
AstraZeneca, Tesaro and Clovis need to slash the cost of PARP meds, watchdog says
Submitted by
admin
on October 2, 2017 - 10:10pm
Source:
Fierce Pharma
News Tags:
AstraZeneca
Tesaro
Clovis Oncology
PARP inhibitors
drug pricing
ovarian cancer
Lynparza
Zejula
Rubraca
Headline:
AstraZeneca, Tesaro and Clovis need to slash the cost of PARP meds, watchdog says
Do Not Allow Advertisers to Use My Personal information
